Kevin was Managing Director of GSTS Pathology, a unique joint venture between the NHS and the private sector, set up to improve the way pathology is delivered in the UK. Prior to this, he was President of Avecia Biologics, a leading UK-based bio-manufacturing company.
Kevin chaired the advisory committee of BioNow (the North West's biomedical cluster organisation) and UKTI's biotechnology and pharmaceuticals sector advisory group. He is currently a Non-Executive Director for the British Neuroscience Association (BNA) and a board member for the BIA.
Kevin took his degree in Chemistry at Sheffield University, and gained his doctorate degree at Balliol College, Oxford.